SLENYTO cpr ret 1 mg 60 pce

7680674220015 CH-67422 N05CH01 01.03.1.

Reimbursement limitations:

SLENYTO

Après accord sur la prise en charge des frais par l’assureur-maladie suivant la consultation préalable …

SLENYTO cpr ret 1 mg 60 pce
SLENYTO cpr ret 1 mg 60 pce
SLENYTO cpr ret 1 mg 60 pce
1 / 3
google

Details

Product number
6742201
CPT
-
Packaging group
60
Unit
Tablette(n)
Composition
melatoninum 1 mg, ammonio methacrylatis copolymerum B, calcii hydrogenophosphas dihydricus, lactosum monohydricum 8.75 mg, silica colloidalis anhydrica, talcum, magnesii stearas, carmellosum natricum corresp. natrium max. 54.6 µg, maltodextrinum, glucosum monohydricum 0.157 mg, lecithinum, E 171, E 172 (rubrum), E 172 (flavum), pro compresso obducto.

Articles (1)

Slenyto 1 mg, Retardtabletten
Tabletten
60
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
25/08/2025
Patient information leaflet
Français
25/08/2025
Patient information leaflet
Italien
25/08/2025
Professional SmPC
Allemand
25/08/2025
Professional SmPC
Français
25/08/2025
Professional SmPC
Italien
25/08/2025

Detailed composition

Substance Quantity Type Category
(N/A)
1.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
8.75 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
0.157 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance FTODK
(N/A)
- Substance FTODK

Reimbursement information

Public price
CHF 59.20
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/01/2023

Authorization holder

NEURIM PHARMACEUTICALS AG

6312 Steinhausen

Authorization information

Swissmedic authorization number
67422
Drug name
Slenyto, Retardtabletten
Galenic form
RETT
ATC Code
N05CH01
Authorization status
Z
Dispensation category
B
First authorization
18/07/2019
Authorization expiration date
31/12/9999
IT number
01.03.1.
Domain
Human medicine
Field of application
Schlafstörungen (lnsomnie) bei Kindern und Jugendlichen im Alter von 2-18 Jahren mit Autismus-Spektrum-Störung (ASS) und/oder neurogenetischen Störungen mit abweichender diurnaler Melatoninsekretion und/oder nächtlichem Erwachen und bei Kindern und Jugendlichen im Alter von 6–17 Jahren mit Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung (ADHS), wenn jeweils Schlafhygienemassnahmen unzureichend waren.

Packaging details

Description (FR)
SLENYTO cpr ret 1 mg 60 pce
Description (DE)
SLENYTO Ret Tabl 1 mg 60 Stk
Market launch
18/07/2019
Narcotic (BTM)
No

Other packaging sizes

SLENYTO cpr ret 5 mg 30 pce
30 TABL
GTIN: 7680674220022
View